糖呼吸型糖聚合物调节葡萄糖水平
Yufen Xiao1, Hui Sun1, Jianzhong Du1,2
1Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University , 4800 Caoan Road, Shanghai 201804, China.
Journal of the American Chemical Society
|May 17, 2017
概括
这项研究引入了一种新的"糖海绵"纳米结构, 这种创新方法通过模仿天然葡萄糖调节提供了潜在的新型糖尿病治疗方法.
科学领域:
- 生物材料科学
- 纳米技术
- 内分泌学
背景情况:
- 糖尿病是一种慢性疾病,需要每天注射胰岛素来调节血糖.
- 目前的糖尿病治疗常常需要经常注射胰岛素,这给患者带来负担.
研究的目的:
- 开发一种使用新型纳米结构的非胰岛素,无药物血糖调节策略.
- 研究一种与莱克结合的糖聚合体作为一种对葡萄糖反应的治疗剂的潜力.
主要方法:
- 用莱克功能化的糖聚合体 (PEO-b-P ((CMA-stat-DEA-stat-GEMA)) 的自组合.
- 葡萄糖结合和释放动态的体外特征,包括尺寸变化.
- 在I型糖尿病小鼠中对抗糖尿病功效的体内评估.
主要成果:
- 在
- 糖海绵
- 基于度的动态葡萄糖吸收和释放.
- 在体外观察到显著的尺寸变化,表明葡萄糖反应.
- 在糖尿病小鼠中,单剂可有效控制血糖超过2天.
结论:
- 结合莱克的糖聚合体作为一种
- 糖海绵
- 提供一种新的血糖管理方法.
- 这种策略为糖尿病治疗提供了一个有前途的无胰岛素和无药物替代方案.
- 在
- 糖海绵
- 这一概念为糖尿病开辟了新的治疗途径.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
684
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
684
Hormones Regulating Blood Glucose
7.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.6K
Glucose Homeostasis: Regulation of Blood Glucose
4.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.8K
Oligosaccharide Assembly
3.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.8K
Biosynthesis of Polysaccharides
779
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
779
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K


